Logo image of 703.DE

ALFEN N.V. (703.DE) Stock Fundamental Analysis

FRA:703 - Deutsche Boerse Ag - NL0012817175 - Common Stock - Currency: EUR

11.25  +0.36 (+3.31%)

Fundamental Rating

4

Taking everything into account, 703 scores 4 out of 10 in our fundamental rating. 703 was compared to 52 industry peers in the Electrical Equipment industry. The financial health of 703 is average, but there are quite some concerns on its profitability. 703 has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

703 had negative earnings in the past year.
703 had a positive operating cash flow in the past year.
Of the past 5 years 703 4 years were profitable.
In the past 5 years 703 always reported a positive cash flow from operatings.
703.DE Yearly Net Income VS EBIT VS OCF VS FCF703.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M

1.2 Ratios

703's Return On Assets of -7.45% is on the low side compared to the rest of the industry. 703 is outperformed by 71.15% of its industry peers.
The Return On Equity of 703 (-17.74%) is worse than 69.23% of its industry peers.
Industry RankSector Rank
ROA -7.45%
ROE -17.74%
ROIC N/A
ROA(3y)5.52%
ROA(5y)7.16%
ROE(3y)11.34%
ROE(5y)14.49%
ROIC(3y)N/A
ROIC(5y)N/A
703.DE Yearly ROA, ROE, ROIC703.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40

1.3 Margins

703 has a Gross Margin (31.09%) which is in line with its industry peers.
703's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for 703 so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 31.09%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.42%
GM growth 5Y-4.61%
703.DE Yearly Profit, Operating, Gross Margins703.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

5

2. Health

2.1 Basic Checks

703 does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for 703 remains at a similar level compared to 1 year ago.
703 has more shares outstanding than it did 5 years ago.
The debt/assets ratio for 703 has been reduced compared to a year ago.
703.DE Yearly Shares Outstanding703.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
703.DE Yearly Total Debt VS Total Assets703.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

703 has an Altman-Z score of 2.49. This is not the best score and indicates that 703 is in the grey zone with still only limited risk for bankruptcy at the moment.
703's Altman-Z score of 2.49 is fine compared to the rest of the industry. 703 outperforms 75.00% of its industry peers.
The Debt to FCF ratio of 703 is 1.59, which is an excellent value as it means it would take 703, only 1.59 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 1.59, 703 belongs to the top of the industry, outperforming 88.46% of the companies in the same industry.
A Debt/Equity ratio of 0.28 indicates that 703 is not too dependend on debt financing.
703's Debt to Equity ratio of 0.28 is fine compared to the rest of the industry. 703 outperforms 75.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.28
Debt/FCF 1.59
Altman-Z 2.49
ROIC/WACCN/A
WACC7.16%
703.DE Yearly LT Debt VS Equity VS FCF703.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

703 has a Current Ratio of 1.68. This is a normal value and indicates that 703 is financially healthy and should not expect problems in meeting its short term obligations.
703's Current ratio of 1.68 is in line compared to the rest of the industry. 703 outperforms 59.62% of its industry peers.
A Quick Ratio of 1.00 indicates that 703 may have some problems paying its short term obligations.
703 has a Quick ratio (1.00) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.68
Quick Ratio 1
703.DE Yearly Current Assets VS Current Liabilites703.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

4

3. Growth

3.1 Past

The earnings per share for 703 have decreased strongly by -191.15% in the last year.
703 shows a decrease in Revenue. In the last year, the revenue decreased by -3.34%.
The Revenue has been growing by 27.79% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-191.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-178.64%
Revenue 1Y (TTM)-3.34%
Revenue growth 3Y25%
Revenue growth 5Y27.79%
Sales Q2Q%67.79%

3.2 Future

703 is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 55.47% yearly.
Based on estimates for the next years, 703 will show a small growth in Revenue. The Revenue will grow by 4.40% on average per year.
EPS Next Y527.24%
EPS Next 2Y184.12%
EPS Next 3Y101.07%
EPS Next 5Y55.47%
Revenue Next Year1.97%
Revenue Next 2Y5.44%
Revenue Next 3Y6.31%
Revenue Next 5Y4.4%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
703.DE Yearly Revenue VS Estimates703.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M
703.DE Yearly EPS VS Estimates703.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.5 1 1.5 2

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for 703. In the last year negative earnings were reported.
The Price/Forward Earnings ratio is 16.49, which indicates a correct valuation of 703.
Compared to the rest of the industry, the Price/Forward Earnings ratio of 703 indicates a somewhat cheap valuation: 703 is cheaper than 65.38% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.77, 703 is valued a bit cheaper.
Industry RankSector Rank
PE N/A
Fwd PE 16.49
703.DE Price Earnings VS Forward Price Earnings703.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of 703 indicates a rather cheap valuation: 703 is cheaper than 88.46% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 7.83
EV/EBITDA N/A
703.DE Per share data703.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as 703's earnings are expected to grow with 101.07% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y184.12%
EPS Next 3Y101.07%

0

5. Dividend

5.1 Amount

703 does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ALFEN N.V.

FRA:703 (5/26/2025, 7:00:00 PM)

11.25

+0.36 (+3.31%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)05-12 2025-05-12
Earnings (Next)08-20 2025-08-20
Inst Owners48.06%
Inst Owner ChangeN/A
Ins Owners0.55%
Ins Owner ChangeN/A
Market Cap244.69M
Analysts76
Price Target16.41 (45.87%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)3.76%
PT rev (3m)-0.43%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)5.74%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.88%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 16.49
P/S 0.5
P/FCF 7.83
P/OCF 4.38
P/B 1.61
P/tB 1.95
EV/EBITDA N/A
EPS(TTM)-1.24
EYN/A
EPS(NY)0.68
Fwd EY6.06%
FCF(TTM)1.44
FCFY12.77%
OCF(TTM)2.57
OCFY22.81%
SpS22.42
BVpS7
TBVpS5.76
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.45%
ROE -17.74%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 31.09%
FCFM 6.41%
ROA(3y)5.52%
ROA(5y)7.16%
ROE(3y)11.34%
ROE(5y)14.49%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.42%
GM growth 5Y-4.61%
F-Score5
Asset Turnover1.34
Health
Industry RankSector Rank
Debt/Equity 0.28
Debt/FCF 1.59
Debt/EBITDA N/A
Cap/Depr 93.52%
Cap/Sales 5.04%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.68
Quick Ratio 1
Altman-Z 2.49
F-Score5
WACC7.16%
ROIC/WACCN/A
Cap/Depr(3y)181.87%
Cap/Depr(5y)166.2%
Cap/Sales(3y)5.57%
Cap/Sales(5y)5.29%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-191.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-178.64%
EPS Next Y527.24%
EPS Next 2Y184.12%
EPS Next 3Y101.07%
EPS Next 5Y55.47%
Revenue 1Y (TTM)-3.34%
Revenue growth 3Y25%
Revenue growth 5Y27.79%
Sales Q2Q%67.79%
Revenue Next Year1.97%
Revenue Next 2Y5.44%
Revenue Next 3Y6.31%
Revenue Next 5Y4.4%
EBIT growth 1Y-172.85%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year726.38%
EBIT Next 3Y136.35%
EBIT Next 5Y74.68%
FCF growth 1Y207.54%
FCF growth 3YN/A
FCF growth 5Y33.38%
OCF growth 1Y890.24%
OCF growth 3Y74.32%
OCF growth 5Y31.69%